Literature DB >> 29517026

How CRISPR is transforming drug discovery.

Andrew Scott.   

Abstract

Mesh：

Year:  2018        PMID： 29517026     DOI： 10.1038/d41586-018-02477-1

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

Review 1.  Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling.

Authors:  Linlin Zhao; Heather L Ciallella; Lauren M Aleksunes; Hao Zhu
Journal:  Drug Discov Today       Date:  2020-07-11       Impact factor: 7.851

Review 2.  Liposomal delivery of CRISPR/Cas9.

Authors:  Shuai Zhen; Xu Li
Journal:  Cancer Gene Ther       Date:  2019-11-02       Impact factor: 5.987

Review 3.  Intrauterine Hypoxia and Epigenetic Programming in Lung Development and Disease.

Authors:  Yajie Tong; Shuqing Zhang; Suzette Riddle; Lubo Zhang; Rui Song; Dongmei Yue
Journal:  Biomedicines       Date:  2021-08-02

Review 4.  Personalized Cancer Models for Target Discovery and Precision Medicine.

Authors:  Carla Grandori; Christopher J Kemp
Journal:  Trends Cancer       Date:  2018-08-08

Review 5.  Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.

Authors:  Erik Tambuyzer; Benjamin Vandendriessche; Christopher P Austin; Philip J Brooks; Kristina Larsson; Katherine I Miller Needleman; James Valentine; Kay Davies; Stephen C Groft; Robert Preti; Tudor I Oprea; Marco Prunotto
Journal:  Nat Rev Drug Discov       Date:  2019-12-13       Impact factor: 84.694

Review 6.  Vector engineering, strategies and targets in cancer gene therapy.

Authors:  Vijayata Singh; Nusrat Khan; Giridhara R Jayandharan
Journal:  Cancer Gene Ther       Date:  2021-04-15       Impact factor: 5.987

Review 7.  Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery.

Authors:  Claudia De Masi; Paola Spitalieri; Michela Murdocca; Giuseppe Novelli; Federica Sangiuolo
Journal:  Hum Genomics       Date:  2020-06-26       Impact factor: 4.639

Review 8.  Drug Combination in Cancer Treatment-From Cocktails to Conjugated Combinations.

Authors:  Yosi Gilad; Gary Gellerman; David M Lonard; Bert W O'Malley
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

Review 9.  Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review).

Authors:  Meryem Alagoz; Nasim Kherad
Journal:  Int J Mol Med       Date:  2020-05-19       Impact factor: 4.101
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.